NeueHealth, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- George Lawrence Mikan III
- Full Time Employees
- 986
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Address
- 9250 NW 36th St Doral FL United States of America 33178
- IPO Date
- Jun 24, 2021
- CIK
- 0001671284
- Website
- neuehealth.com
- Similar Companies
- Business
- NeueHealth, Inc. NeueHealth, Inc. (NYSE: NEUE) operates as a value-driven healthcare company that delivers coordinated care services to health consumers, providers, and payors across the ACA marketplace, Medicare, and Medicaid populations in the United States. The company functions through two primary segments, NeueCare and NeueSolutions; NeueCare provides accessible, affordable healthcare via owned and affiliated clinics under brands such as Centrum Health and Premier Medical Associates, encompassing integrated solutions including embedded pharmacy, laboratory, radiology, population health-focused specialty services, chronic care management, transitions of care, and referral management; NeueSolutions equips independent providers and medical groups for performance-based arrangements with financial alignment tools, customized population health platforms, and partnerships involving leading health plans and government programs like the Centers for Medicare and Medicaid Innovation’s ACO REACH initiative. Founded in 2015 and headquartered in Doral, Florida, NeueHealth, Inc. serves over 500,000 consumers nationwide through more than 3,000 affiliated providers, emphasizing consumer-centric care delivery and value-based models that enhance outcomes while controlling costs. In a significant strategic shift, the company, formerly known as Bright Health Group, Inc., rebranded to NeueHealth, Inc. in January 2024 and completed a take-private acquisition by an affiliate of New Enterprise Associates (NEA) and a consortium of investors for approximately $1.465 billion in early 2025, delisting from public trading to prioritize long-term growth in value-based care.
NeueHealth Announces Closing of Take-Private Transaction
NeueHealth, Inc. (NEUE) Q2 2025 Earnings Call Transcript
Transcript : NeueHealth, Inc., Q2 2025 Earnings Call, Aug 07, 2025
NeueHealth Reports Second Quarter 2025 Results
NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025
NeueHealth, Inc (NEUE) Q1 2025 Earnings Call Transcript
NeueHealth Reports First Quarter 2025 Results
NeueHealth to Host First Quarter 2025 Earnings Conference Call on May 8, 2025
NEUEHEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NeueHealth, Inc. - NEUE
NeueHealth, Inc (NEUE) Q4 2024 Earnings Call Transcript
NeueHealth Reports Fourth Quarter and Full Year 2024 Results
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into NeueHealth Inc. ("NEUE").
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEUE, ESSA, LTRPA on Behalf of Shareholders
Bronstein, Gewirtz & Grossman, LLC Is Investigating NeueHealth, Inc. (NEUE) And Encourages Shareholders to Connect
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeueHealth, Inc. (NEUE) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeueHealth, Inc. (NEUE) and Encourages Shareholders to Learn More About the Investigation
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm
The Schall Law Firm Invites Investors With Losses To Join An Investigation Into NeueHealth, Inc. For Securities Fraud
NeueHealth, Inc. (NEUE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NeueHealth, Inc. Is Being Investigated For Securities Law Violations And Affected Shareholders Are Urged To Contact The Schall Law Firm